Subject matters | Details | Categories |
---|---|---|
Health
|
Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors
|
Policies or Program
|
Federal-Provincial Relations,
Health
|
Approaches towards National Pharmacare policy
|
Policies or Program
|
Aboriginal Affairs,
Health
|
Development of screening programs in First Nations communities
|
Policies or Program
|
Health
|
Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals
|
Policies or Program
|
Economic Development,
Health
|
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
|
Policies or Program,
Regulation
|
Health
|
Health Canada, with respect to the role of wholesalers in the management of drug shortages
|
Policies or Program
|
Health
|
Medical cannabis policy impacts on pharmacy and the wholesale industry
|
Policies or Program
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Approaches towards National Pharmacare policy
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Development of screening programs in First Nations communities
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Health Canada, with respect to the role of wholesalers in the management of drug shortages
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Medical cannabis policy impacts on pharmacy and the wholesale industry
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Date | DPOH, Position Title | Government Institution | Subject Matters |
---|---|---|
2024-09-05 |
|
Health |
2024-09-05 |
|
Health |
2024-09-05 |
|
Health |
2024-08-22 |
|
Health |
2024-07-05 |
|
Health |
2024-02-14 |
|
Health |
2023-11-29 |
|
Health |
2023-11-29 |
|
Health |
2023-11-28 |
|
Health |
2023-11-28 |
|
Health |
2023-11-28 |
|
Health |